key: cord-0733057-242cb7b6 authors: Chan, Jasper Fuk-Woo; Zhang, Anna Jinxia; Yuan, Shuofeng; Poon, Vincent Kwok-Man; Chan, Chris Chung-Sing; Lee, Andrew Chak-Yiu; Chan, Wan-Mui; Fan, Zhimeng; Tsoi, Hoi-Wah; Wen, Lei; Liang, Ronghui; Cao, Jianli; Chen, Yanxia; Tang, Kaiming; Luo, Cuiting; Cai, Jian-Piao; Kok, Kin-Hang; Chu, Hin; Chan, Kwok-Hung; Sridhar, Siddharth; Chen, Zhiwei; Chen, Honglin; To, Kelvin Kai-Wang; Yuen, Kwok-Yung title: Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility date: 2020-03-26 journal: Clin Infect Dis DOI: 10.1093/cid/ciaa325 sha: 6ac544ebb283cb03324dc7c36535b77a202bb921 doc_id: 733057 cord_uid: 242cb7b6 BACKGROUND: A physiological small animal model that resembles COVID-19 with low mortality is lacking. METHODS: Molecular docking on the binding between angiotensin-converting enzyme 2 (ACE2) of common laboratory mammals and the receptor-binding domain of the surface spike protein of SARS-CoV-2 suggested that the golden Syrian hamster is an option. Virus challenge, contact transmission, and passive immunoprophylaxis were performed. Serial organ tissues and blood were harvested for histopathology, viral load and titre, chemokine/cytokine assay, and neutralising antibody titre. RESULTS: The Syrian hamster could be consistently infected by SARS-CoV-2. Maximal clinical signs of rapid breathing, weight loss, histopathological changes from the initial exudative phase of diffuse alveolar damage with extensive apoptosis to the later proliferative phase of tissue repair, airway and intestinal involvement with virus nucleocapsid protein expression, high lung viral load, and spleen and lymphoid atrophy associated with marked cytokine activation were observed within the first week of virus challenge. The lung virus titre was between 10(5)-10(7) TCID(50)/g. Challenged index hamsters consistently infected naïve contact hamsters housed within the same cage, resulting in similar pathology but not weight loss. All infected hamsters recovered and developed mean serum neutralising antibody titre ≥1:427 fourteen days post-challenge. Immunoprophylaxis with early convalescent serum achieved significant decrease in lung viral load but not in lung pathology. No consistent non-synonymous adaptive mutation of the spike was found in viruses isolated from infected hamsters. CONCLUSIONS: Besides satisfying the Koch’s postulates, this readily available hamster model is an important tool for studying transmission, pathogenesis, treatment, and vaccination against SARS-CoV-2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a looming pandemic of Coronavirus Disease 2019 . 1 This newly emerged coronavirus belongs to the genus Betacoronavirus which also includes the highly pathogenic SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). 2 Phylogenetic analysis suggested that all three coronaviruses have likely originated from bats. 3 SARS-CoV-2 was first identified in patients with atypical pneumonia geographically linked to a wet market with wild animal trade in Wuhan, China. The virus is highly transmissible among humans with clusters occurring among close contacts in family, church, community, cruise ship, nursing home, and hospital settings. 2, [4] [5] [6] [7] Within just three months, >100,000 cases of COVID-19 with >3000 deaths have been reported globally in >100 countries/territories. 8 As readily available and suitable experimental animal models are lacking, the major route of transmission is speculated to be through respiratory droplets, direct or indirect contact with other infectious bodily fluids, such as saliva, faeces, tears, and blood. Recent data showed that the clinical severity of COVID-19 ranges widely from asymptomatic infection to fatal disease. In children, COVID-19 is usually asymptomatic or mildly symptomatic. 2, 9 The majority of immunocompetent adult COVID-19 patients present with fever, respiratory symptoms, and radiological ground-glass lung opacities. 10 In severe cases especially among elderly and immunocompromised patients, besides respiratory failure, extrapulmonary manifestations such as diarrhoea, confusion, hepatic and renal dysfunction, lymphopenia, thrombocytopenia, and elevated inflammatory biomarkers have also been reported. 10 Small animal models that recapitulate the clinical and pathological features of COVID-19 in human are essential tools for studying the pathogenesis, transmission, antiviral treatments, and vaccines for this emerging global health threat. Based on the recent identification 6 of human angiotensin-converting enzyme 2 (ACE2) as the cell entry receptor of SARS-CoV-2, a transgenic human ACE2 mouse model was preliminarily reported. 11 However, the expression of human ACE2 in these transgenic mice is not physiological and these mice are not readily available. A rhesus macaque model was also reported, but expertise and Biosafety Level-3 facilities to handle non-human primates are scarce. 11 In this study, we established a readily available small animal model for COVID-19 using golden Syrian hamster (Mesocricetus auratus). Our in silico structural analysis predicted that the hamster ACE2 can bind with SARS-CoV-2 spike glycoprotein receptor-binding domain (RBD) at high binding affinity. The clinical features, viral kinetics, histopathological changes, and immune responses in SARS-CoV-2infected Syrian hamsters closely mimic those described in many COVID-19 patients. Using this newly established model, we demonstrated the high transmissibility of SARS-CoV-2 among close contact animals. Multiple sequence alignment was generated using the human, rhesus macaque, common marmoset, hamster, rabbit, ferret, rat, mouse, pig, and bat ACE2 protein sequences (Uniprot accession numbers Q9BYF1, B6DUF3, F7CNJ6, G1TEF4, A0A1U7QTA1, Q2WG88, Q5EGZ1, Q8R0I0, K7GLM4, and E2DHI7, respectively) with MUSCLE. 12 Missing loop residues in the SARS-CoV-2 spike protein RBD (PDB ID:6VSB) was modelled with I-TASSER. 13 The human ACE2 and SARS-CoV-spike complex structure model (PDB ID:2AJF) was used to model ACE2 and SARS-CoV-2-spike complex by superposition of SARS-CoV-2-RBD to SARS-CoV-RBD. ACE2-spike complexes of SARS-CoV-2 and SARS-CoV were then minimized with Rosetta 7 Relax application. 14 ACE2-spike interface binding energy was calculated by InterfaceAnalyzer within Rosetta. Interface binding energies of other species were calculated by introducing mutations to the interface according to the amino acid differences with Rosetta protein-protein ΔΔG protocol. Amino acid residues of ACE2 within 4.0Å of SARS-CoV-2 spike RBD were considered as interacting residues. Pymol was used to highlight the interacting sites in red in the ACE2 structure and to show the hydrogen bonds in yellow dash lines. SARS-CoV-2 was isolated from the nasopharyngeal aspirate specimen of a laboratory-confirmed COVID-19 patient in Hong Kong. 15 The plaque purified viral isolate was amplified by one additional passage in VeroE6 cells to make working stocks of the virus as described previously. 15 All experiments involving live SARS-CoV-2 followed the approved standard operating procedures of the HKU Biosafety Level-3 facility. Approval was obtained from the HKU Committee on the Use of Live Animals in Teaching and Research. Male and female Syrian hamsters, aged 6-10 weeks old, were obtained from HKU Laboratory Animal Unit. The animals were kept in Biosafety Level-2 housing and given access to standard pellet feed and water ad libitum until virus challenge in our Biosafety Level-3 animal facility. Phosphate-buffered saline(PBS) was used to dilute virus stocks to the desired concentration, and inocula were back-titrated to verify the dose given. Dulbecco's Modified Eagle Medium(DMEM) containing 10 5 plaque-forming units in 100µl of SARS-CoV-2 was intranasally inoculated under intraperitoneal ketamine(200mg/kg) and xylazine(10mg/kg) 8 anaesthesia. Mock-infected animals were challenged with 100ul of PBS. Animals were monitored twice daily for clinical signs of disease(Supplementary Figure S1 ). Their body weight and survival were monitored for 14 days post-inoculation(dpi). Five animals in each group were sacrificed at 2dpi, 4dpi, and 7dpi for virological and histolopathological analyses. Remaining animals were sacrificed at 14dpi. Blood and major organ tissues at necropsy were separated into two parts, one immediately fixed in 10% PBS-buffered formalin, the other immediately frozen at -80°C until use. These staining and microscopy procedures on tissue sections were performed as described previously with modifications(Supplementary Materials). 16 Viral load studies by qRT-PCR assay were conducted on the blood and organ tissues. Table S1 ). 17 Neutralising antibody detection and passive immunisation 9 Serum anti-SARS-CoV-2 neutralising antibody detection by microneutralisation assay and passive immunisation were performed as described previously(Supplementary Materials). 18, 19 Transmission study among close contact animals Eight hamsters were intranasally challenged with SARS-CoV-2 (0dpi)(Supplementary Figure S2 ). Twenty-four hours later(1dpi), each SARS-CoV-2-challenged hamster was transferred to a new cage with each cage containing one naïve hamster as close contact. Five virus-challenged and five contact hamsters were sacrificed for viral load and histopathological studies at 4dpi and 4 days post-exposure, respectively. The remaining hamsters were kept for clinical observation until 14dpi. Surface spike gene of viral isolates from the hamsters was Sanger sequenced as described previously. 2 All data were analysed with GraphPad Prism software(GraphPad Software,Inc). Weight losses were compared using two-way ANOVA and Student's t-test was used to determine significant differences in virus titres among the different groups. 16 P<0.05 was considered statistically significant. The sponsors had no role in study design, data collection, analysis, interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. As the binding affinity of ACE2 to SARS-CoV-2 surface spike glycoprotein may be dictated by the amino acid composition at the binding interface, structural analysis was performed, which predicted 29 amino acid residues at the ACE2 interface that may interact with the SARS-CoV-2 spike glycoprotein RBD(Figure1A&1B). Comparison of the 29 amino acid residues' alignment between human and other mammalian species revealed that the rhesus macaque ACE2 is 100% identical to human ACE2 at the interface region. Syrian hamster and common marmoset ACE2 proteins are also highly similar to human ACE2, each with 3-4 mutations at the interface. The Table S2 ). Notably, SARS-CoV-2 spike exhibited higher binding affinity with ACE2 than did SARS-CoV spike. This might be attributed to the more compact interacting interface with more hydrogen bonds formed between SARS-CoV-2 spike glycoprotein RBD and ACE2( Figure 1C To investigate the tissue tropism of SARS-CoV-2 in Syrian hamsters, we performed viral load studies on the upper respiratory tract(nasal turbinate), lower respiratory tract (trachea and lung), extrapulmonary organs(intestine, salivary glands, heart, liver, spleen, lymph nodes, kidney, and brain), and blood harvested from virus-challenged animals at different time points which represented the early(2dpi), severe(4dpi), and start of recovery(7dpi) phases. The mean viral loads(Figure2B) in the nasal turbinate and lung(10 2 -10 3 genome copies/β-actin), and trachea(10 1 genome copies/β-actin) were consistently the highest among all tested organ tissues from 2dpi to 7dpi. The viral loads progressively decreased in airway tissues from 2dpi-7dpi. Viral culture of lung tissues showed high titre of 10 5 -10 7 TCID50/g at 2dpi&4dpi(Figure2C). As for extrapulmonary tissues, the mean viral load in the intestine was also highish especially on 4dpi. For other organ or blood, low mean viral loads(<1genome copy/β-actin) were detected at 2dpi and peaked at 4dpi, then progressively reduced to undetectable levels at 7dpi in most samples. The nasal turbinate epithelium was intact with submucosal infiltration and blood vessel To study the transmissibility among close contacts, we housed SARS-CoV The clinical and histopathological findings from this SARS-CoV-2 hamster model closely resemble the manifestations of upper and lower respiratory tract infection in humans. The airway involvement is evident from nasal turbinate to trachea and pulmonary alveoli associated with changes of inflammation, cellular viral N protein expression, and high viral load during the first week. The disease progressed with increasing respiratory rate, decreasing activity, and progressive weight loss, and was most severe by 6dpi which is similar to the disease course of COVID-19 patients. 20 Histopathology showed progression from the initial phase of exudative inflammation to diffuse alveolar damage with haemorrhage and necrosis, and finally the proliferative phase after one week. Our findings were in agreement with the human autopsy findings except that our model also demonstrated extensive tissue apoptosis. 21 None of the challenged or contact hamsters died as <5% of human infections are lethal. 10 As for extrapulmonary manifestations, though diarrhoea is not clinically evident in challenged hamsters, histopathology showed intestinal mucosal inflammation, epithelial necrosis and viral N protein expression in enterocytes. This finding corroborates with the clinical manifestation of diarrhoea in only 2.0%-10.1% of COVID-19 patients despite that up to 53% of their stool samples are RT-PCR positive. 7, 22, 23 Myocardial degenerative changes were noted both in our infected hamster and patient autopsy despite the absence of viral antigen detection in the tissues, which is also consistent with the occasional report of heart failure in COVID-19 patients. 22 Lymphoid atrophy and apoptosis in spleen were observed which correlate with the frequent clinical finding of lymphopenia(83.2%). 10 The lymphoid necrosis is largely related to the marked activation of innate immune response in infected hamsters with high levels of fermenters that eat their own faeces, a feeding behaviour called coprophagy, to recover nutrients digested in the hind-gut but unabsorbed. 29 Thus, faecal-oral route of transmission could not be excluded in this model as well as in human. Readily available small animal models that resemble the clinical and pathological features of human COVID-19 are urgently needed to study pathogenesis, antiviral treatment, and vaccination. The external subdomain of the spike glycoprotein RBD of SARS-CoV-2 shares only 40% amino acid identity with SARS-CoV, but this new virus still utilizes ACE2 as the cell entry receptor which are abundantly found in epithelial linings of human and animals. 3, 30 Our molecular docking and computation showed that the RBD of SARS-CoV-2 binds well with not only the ACE2 of human and macaques, but also with that of Syrian hamsters. Moreover, hamster was demonstrated to be a good model for studying respiratory viruses including SARS-CoV, influenza virus, and adenovirus. 31,32 Unlike our hamster model for SARS-CoV-2, it is also notable that weight loss or intestinal involvement were absent in the hamster model infected by the 2003 SARS-CoV. 31 More importantly, the viral load in the nasal turbinate(7-log10TCID50/gram) of SARS-CoV-2-infected hamsters was consistently about ~1-log higher than that of their lung(~5.5-6-log10TCID50/gram) at 2dpi, 4dpi, and 7dpi, whereas the viral load in the nasal turbinate of the 2003 SARS-CoV-infected hamsters were generally similar or lower than 18 that of the lung. 31 This might help to explain why SARS-CoV-2 is more transmissible as the upper respiratory tract involvement by the virus is no less than that of the lower respiratory tract, whereas SARS-CoV predominantly infects the lower respiratory tract. Our study had a number of limitations. First, the virus inocula used in this study and the previous report of 2003 SARS-CoV hamster model were different, which might contribute to the differences in findings. Second, we tested the mRNA but not protein expression of the hamsters' chemokine/cytokine profiles as enzyme-immunoassay for hamster chemokines/cytokines were unavailable. Finally, we focused our sequencing on the surface spike gene which is essential for virus-host cell entry. Complete genome sequencing may reveal additional adaptive mutations in other genome regions. Nevertheless, unlike non-human primates and ACE2-transgenic mice, this hamster model is readily available, physiological, and highly resembles COVID-19. Thus, it would be an important platform for studying the pathogenesis, transmission, treatments, and vaccines for COVID-19. Author contributions. JF-WC, AJZ, SY, and K-YY had roles in the study design, data collection, data analysis, data interpretation, and writing of the manuscript. VK-MP and CC-SC had roles in the study design, experiments, data collection, data analysis, and data interpretation. The ACE2 amino acid residues within 4.0Å of the SARS-CoV-2 spike glycoprotein S1 subunit RBD are highlighted in red. hydrogen bond donors and acceptors are represented by sticks (oxygen = red sticks; nitrogen = blue sticks; carbon = green sticks in ACE2 and grey sticks in RBDs). Abbreviations: FP, fusion peptide; HR1, heptad repeat 1; HR2, heptad repeat 1 and 2; NTD, Nterminal domain; RBD, receptor-binding domain; S1, Spike S1 subunit; S2, Spike S2 subunit; SP, signal peptide; TM, Transmembrane domain. A Novel Coronavirus from Patients with Pneumonia in China A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan South Korea's coronavirus cases climb above 7,000, most cases traced to church COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures The Wall Street Journal: Coronavirus Spreads to More Elder Facilities in Seattle Area Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China World Health Organisation Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China Clinical Characteristics of Coronavirus Disease How monkeys, mice and ferrets are helping scientists to fight coronavirus MUSCLE: multiple sequence alignment with high accuracy and high throughput I-TASSER server for protein 3D structure prediction Macromolecular modeling with rosetta Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcriptionpolymerase chain reaction assay validated in vitro and with clinical specimens Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis Temporal profiles of deep throat saliva viral load and serum antibody response during COVID-19 infection by SARS-CoV-2: an observational cohort study Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Viral load of SARS-CoV-2 in clinical samples Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Two years after pandemic influenza H1N1: what have we learned? Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection Rodent nutrition: digestive comparisons of 4 common rodent species A pneumonia outbreak associated with a new coronavirus of probable bat origin Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Syrian Hamster as an Animal Model for the Study on Infectious Diseases Potential conflicts of interests. We declare no competing interests.